Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Early Development
    • Late Development
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

CatSci Patent

Categories
BlogBook ChaptersCase StudiesPapersPatentsPresentationsThought LeadersWebinarsWhitepapers
Tags
Analytical Chemistry Analytical Science Artificial Intelligence (AI) Biocatalysis Catalysis CatSci Paper CatSci Patent Chemical Development Design of Experiments Digital Drug Development Experimental Design Green Chemistry Industry insights Innovation Machine Learning (ML) Material Science Medium Throughput Experimentation Oligonucleotides Principal Component Analysis Process R&D QbD Route Scouting and Selection Scale-up Scavenging Solvents Sustainability Technology transfer Work-up
Process for the preparation of bromodomain inhibitor

WO2020023438

2020 By Antonio M. Ruda, et al.
Process for the preparation of a stereospecific form of flurbiprofen, or a pharmaceutically ...

WO2016110708

2016 By CatSci team, et al.
Process for the removal and return of a catalyst to a liquid phase medium

WO2014083109

2014 By CatSci team, et al.

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • ESG Report 2022

What we do

  • What we do
    • Late Development
    • Early Development

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in drug development to accelerate the delivery of life-changing medicines to patients in need. 

© 2023 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.